Blood Transfusion Diagnostics Market Analysis

Application (Blood Group Typing, Blood Screening)

The blood transfusion diagnostics market is segmented and analyzed for demand and supply by application into blood group typing and blood screening. Out of the two, the blood screening segment is anticipated to hold the largest market size by the end of 2033. Rising blood donations and transfusions are likely to boost the growth of the segment. By the statistics of the WHO, about 119 million of blood is donated every year all around the world. In addition, the growing penetration of sexually transmitted diseases, hepatitis B, and HIV are driving the segment’s growth. According to the Centers for Disease Control and Prevention, around 296 million people are living with hepatitis B worldwide. Moreover, as per the World Health Organization, the prevalence of STDs has impacted more than 1 million people all over the world.

End-user (Hospital Based Laboratories, Blood Banks)

The global blood transfusion diagnostics market is also segmented and analyzed for demand and supply by end-user in hospital-based laboratories and blood banks. Out of these segments, hospital-based laboratories are projected to secure a higher market share by 2033. This can be owed to the fact that hospital-based laboratories are better equipped to conduct the complicated and crucial screening procedures necessary for blood transfusions since they are furnished with cutting-edge machinery and technology and operated by qualified personnel. Additionally, these labs are in a good position to provide patients with a variety of diagnostic services such as blood typing. Also, hospitals are expanding their diagnostic capabilities to satisfy the rising need for blood products as the demand for blood transfusions rises. For instance, it was found that there were about 6100 hospitals in the U.S. in 2022.

Our in-depth analysis of the global market includes the following segments:

By Product Type	Instruments Reagents & Kits
By Application	Blood Group Typing Blood Screening
By End-User	Hospital Based Laboratories Blood Banks

Frequently Asked Questions (FAQ)

Growing cases of COVID-19, rising road accidents, a dearth of blood donations, and a higher number suffering from kidney issues and chronic disease are the few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2023-2033.

The dearth of skilled technicians, exorbitant prices of tests and instruments, and shortage of infrastructure are the few factors that are likely to hamper the market growth.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc., and so onâ€¦

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-user, and by region.

Blood screening is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Blood Transfusion Diagnostics Market Analysis